Arcellx, INC. (ACLX) — 8-K Filings

8-K Filings (15)

• 8-K Filing — Dec 8, 2025
• Arcellx Files 8-K on Security Holder Votes — May 28, 2025 Risk: low
  Arcellx, Inc. filed an 8-K on May 28, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about
• Arcellx, Inc. Files 8-K Report — May 14, 2025 Risk: low
  Arcellx, Inc. filed an 8-K on May 14, 2025, reporting other events and financial statements. The company, incorporated in Delaware with its principal executive
• Arcellx, Inc. Files 8-K on Operations and Financials — May 8, 2025 Risk: low
  Arcellx, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition, as well as filing financial statements and exhibits.
• Arcellx, Inc. Files 8-K: Director/Officer Changes & More — Mar 20, 2025 Risk: medium
  Arcellx, Inc. filed an 8-K on March 20, 2025, reporting events as of March 17, 2025. The filing indicates changes related to the departure and election of direc
• Arcellx Files 8-K on Operations and Financials — Feb 27, 2025 Risk: low
  Arcellx, Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits
• Arcellx, Inc. Files 8-K Report — Dec 12, 2024 Risk: low
  Arcellx, Inc. filed an 8-K on December 12, 2024, reporting other events and financial statements/exhibits. The filing date for the report was December 9, 2024.
• Arcellx, Inc. Files 8-K: Corporate and Financial Update — Dec 9, 2024 Risk: low
  Arcellx, Inc. filed an 8-K on December 9, 2024, reporting other events and financial statements. The filing details the company's corporate structure and operat
• Arcellx, Inc. Files 8-K Report — Nov 7, 2024 Risk: low
  On November 7, 2024, Arcellx, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing does not contain specific financi
• Arcellx, Inc. Files 8-K Report — Nov 5, 2024 Risk: low
  Arcellx, Inc. filed an 8-K on November 5, 2024, reporting other events and financial statements. The company, incorporated in Delaware, is involved in biologica
• Arcellx, Inc. Files 8-K Report — Aug 8, 2024 Risk: low
  On August 8, 2024, Arcellx, Inc. filed an 8-K report detailing its financial results and business updates. The company, incorporated in Delaware, is focused on
• Arcellx, Inc. Files 8-K on Shareholder Vote Matters — May 29, 2024 Risk: low
  Arcellx, Inc. filed an 8-K on May 29, 2024, reporting on matters submitted to a vote of its security holders as of May 24, 2024. The filing details the company'
• Arcellx, Inc. Files 8-K for Operations and Financials — May 9, 2024 Risk: low
  Arcellx, Inc. filed an 8-K on May 9, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits.
• Arcellx Licenses CART-ddBCMA to Kite Pharma for $125M Upfront — Mar 14, 2024 Risk: medium
  Arcellx, Inc. announced on March 8, 2024, that it has entered into a collaboration and license agreement with Kite Pharma, Inc., a Gilead company. This agreemen
• Arcellx Terminates Material Definitive Agreement, Effective Jan 30 — Jan 31, 2024
  Arcellx, Inc. (ACLX) filed an 8-K on January 31, 2024, reporting the termination of a material definitive agreement, effective January 30, 2024. This terminatio

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX